JP2019500051A - 変異ウイルス、その調製方法およびその用途 - Google Patents

変異ウイルス、その調製方法およびその用途 Download PDF

Info

Publication number
JP2019500051A
JP2019500051A JP2018534937A JP2018534937A JP2019500051A JP 2019500051 A JP2019500051 A JP 2019500051A JP 2018534937 A JP2018534937 A JP 2018534937A JP 2018534937 A JP2018534937 A JP 2018534937A JP 2019500051 A JP2019500051 A JP 2019500051A
Authority
JP
Japan
Prior art keywords
virus
mutant
amino acid
trna
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018534937A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019500051A5 (https=
Inventor
デミン チョウ
デミン チョウ
ロンロン シ
ロンロン シ
シューイン チョウ
シューイン チョウ
ツィーウェイ チャン
ツィーウェイ チャン
ファン シュ
ファン シュ
チェンユー ティアン
チェンユー ティアン
チュアンリン チャン
チュアンリン チャン
スロン シャオ
スロン シャオ
チン シア
チン シア
リヘ チャン
リヘ チャン
Original Assignee
ペキン ユニヴァーシティー
ペキン ユニヴァーシティー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ペキン ユニヴァーシティー, ペキン ユニヴァーシティー filed Critical ペキン ユニヴァーシティー
Publication of JP2019500051A publication Critical patent/JP2019500051A/ja
Publication of JP2019500051A5 publication Critical patent/JP2019500051A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation
    • C12N2760/16162—Methods of inactivation or attenuation by genetic engineering
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y601/00—Ligases forming carbon-oxygen bonds (6.1)
    • C12Y601/01—Ligases forming aminoacyl-tRNA and related compounds (6.1.1)
    • C12Y601/01026—Pyrrolysine-tRNAPyl ligase (6.1.1.26)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP2018534937A 2015-12-31 2016-08-02 変異ウイルス、その調製方法およびその用途 Pending JP2019500051A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201511029463.1 2015-12-31
CN201511029463.1A CN106929482A (zh) 2015-12-31 2015-12-31 定点突变的流感病毒、其活疫苗及其制备方法和应用
PCT/CN2016/092778 WO2017113786A1 (zh) 2015-12-31 2016-08-02 突变的病毒、其制备方法和应用

Publications (2)

Publication Number Publication Date
JP2019500051A true JP2019500051A (ja) 2019-01-10
JP2019500051A5 JP2019500051A5 (https=) 2019-06-20

Family

ID=59224413

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018534937A Pending JP2019500051A (ja) 2015-12-31 2016-08-02 変異ウイルス、その調製方法およびその用途

Country Status (11)

Country Link
US (1) US11510974B2 (https=)
EP (1) EP3399029A4 (https=)
JP (1) JP2019500051A (https=)
CN (2) CN106929482A (https=)
AU (1) AU2016383201A1 (https=)
BR (1) BR112018013168A2 (https=)
CA (1) CA3010015A1 (https=)
CO (1) CO2018006706A2 (https=)
IL (1) IL260258A (https=)
WO (1) WO2017113786A1 (https=)
ZA (1) ZA201804362B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112725282A (zh) * 2016-01-27 2021-04-30 北京大学 携带正交tRNA/氨酰tRNA合成酶的稳定细胞系的构建
CN109295100A (zh) * 2017-07-25 2019-02-01 北京大学 携带正交tRNA/氨酰tRNA合成酶的稳定细胞系的构建
CN107964035B (zh) * 2017-12-06 2020-07-24 中国科学院微生物研究所 一种用于流感病毒的有限复制型黏膜免疫疫苗
CN109180680B (zh) * 2018-08-01 2020-05-08 苏州大学 一种紫外光触发交联型近红外分子探针及其制备方法与应用
CN110835633B (zh) * 2018-08-13 2021-10-01 北京大学 利用优化的基因密码子扩展系统制备ptc稳定细胞系及应用
CN110846311A (zh) * 2018-08-20 2020-02-28 北京大学 利用抑制性tRNA系统制备PTC稳定细胞系及应用
CN109111508B (zh) * 2018-09-19 2021-03-19 天康生物股份有限公司 禽流感病毒血凝素抗原及表达其的cho细胞株、制备方法和疫苗
CN109652384B (zh) * 2019-02-21 2021-10-26 昆明理工大学 一种体外培养戊型肝炎病毒的方法
CN109957550B (zh) * 2019-03-13 2020-10-20 浙江森卫生物医药发展有限公司 流感病毒的拯救方法及其组合物
CN109943536B (zh) * 2019-03-26 2021-09-14 昆明理工大学 一种戊型肝炎病毒的培养方法及其灭活疫苗的制备方法
CN110042084A (zh) * 2019-04-11 2019-07-23 浙江森卫生物医药发展有限公司 一种活病毒流感疫苗的生产方法以及制剂
CN109971888A (zh) * 2019-04-11 2019-07-05 浙江森卫生物医药发展有限公司 一种复制可控型流感病毒的检测方法
WO2021004389A1 (zh) * 2019-07-05 2021-01-14 司龙龙 蛋白水解靶向病毒、其活疫苗及其制备方法和用途
CN110743007B (zh) * 2019-09-10 2023-05-30 安徽智飞龙科马生物制药有限公司 一种联合疫苗及其制备方法、应用
CN110845587B (zh) 2019-10-15 2021-06-29 康希诺生物股份公司 一种定点突变的载体蛋白及其在制备疫苗中的用途
CN111533792B (zh) * 2020-07-07 2020-10-16 康希诺生物股份公司 一种定点突变的载体蛋白及其在制备疫苗中的用途
CN113502274A (zh) * 2021-06-21 2021-10-15 武汉大学 一种表达人乳头瘤病毒衣壳蛋白l2的重组流感病毒株及其制备方法与应用
CN115074330B (zh) * 2022-04-19 2023-12-29 中国医学科学院医学生物学研究所 一种基于遗传密码子扩展技术的改造Vero细胞系
WO2024040453A1 (zh) * 2022-08-24 2024-02-29 北京大学宁波海洋药物研究院 突变的流感病毒、药物组合物及用途
CN116804187A (zh) * 2023-07-24 2023-09-26 中国农业科学院兰州兽医研究所 一种复制缺陷型口蹄疫病毒、构建方法及应用
CN116904403B (zh) * 2023-09-13 2024-01-09 北京民海生物科技有限公司 一种腮腺炎病毒突变体及其应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011514322A (ja) * 2008-02-08 2011-05-06 ザ スクリプス リサーチ インスティチュート 遺伝的にコードされる非天然アミノ酸による免疫寛容解除
JP2012503991A (ja) * 2008-09-26 2012-02-16 アンブルックス，インコーポレイテッド 非天然アミノ酸による複製に依存する微生物およびワクチン
CN104592364A (zh) * 2013-10-30 2015-05-06 北京大学 定点突变和定点修饰的腺相关病毒、其制备方法及应用
WO2015120459A2 (en) * 2014-02-10 2015-08-13 Nutech Ventures Live, attenuated vaccines and methods of making and using
JP2015530091A (ja) * 2012-09-24 2015-10-15 メディミューン リミテッド 細胞株

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7083970B2 (en) * 2001-04-19 2006-08-01 The Scripps Research Institute Methods and compositions for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs
MXPA04000589A (es) * 2001-07-20 2005-06-17 Univ Georgia Res Found Virus de la rabia atenuado con mutacion de nucleoproteina en el sitio de fosforilacion para vacunacion contra la rabia y terapia genetica en el snc.
TW201125984A (en) * 2009-10-09 2011-08-01 Univ New York State Res Found Attenuated influenza viruses and vaccines
CN102838663B (zh) * 2011-06-23 2014-06-11 北京大学 定点突变和定点修饰的病毒膜蛋白、其制备方法及其应用
CN102964432B (zh) * 2012-11-22 2014-02-05 中国科学院微生物研究所 抑制a型流感病毒m1蛋白发生磷酸化的方法及其应用
EP3087088B1 (en) * 2013-12-23 2022-05-25 University Of Rochester Methods and compositions for ribosomal synthesis of macrocyclic peptides
CA2936615C (en) * 2014-01-14 2023-06-13 European Molecular Biology Laboratory Multiple cycloaddition reactions for labeling of molecules
MA40773A (fr) * 2014-10-02 2017-08-08 Vertex Pharma Variants du virus influenza a

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011514322A (ja) * 2008-02-08 2011-05-06 ザ スクリプス リサーチ インスティチュート 遺伝的にコードされる非天然アミノ酸による免疫寛容解除
JP2012503991A (ja) * 2008-09-26 2012-02-16 アンブルックス，インコーポレイテッド 非天然アミノ酸による複製に依存する微生物およびワクチン
JP2015530091A (ja) * 2012-09-24 2015-10-15 メディミューン リミテッド 細胞株
CN104592364A (zh) * 2013-10-30 2015-05-06 北京大学 定点突变和定点修饰的腺相关病毒、其制备方法及应用
WO2015120459A2 (en) * 2014-02-10 2015-08-13 Nutech Ventures Live, attenuated vaccines and methods of making and using

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANGEW. CHEM., vol. 52, JPN6020017804, 2013, pages 13970 - 13974, ISSN: 0004514487 *
ANGEW. CHEM., vol. 53, JPN6020017802, 2014, pages 4867 - 4871, ISSN: 0004274537 *
CELL, vol. 19, JPN6021020022, 1980, pages 683 - 696, ISSN: 0004735613 *
NUCLEIC ACIDS RESEARCH, vol. 42, no. 11, JPN6020017806, 2015, pages 73, ISSN: 0004514488 *
PLOS ONE, vol. 9, no. 12, JPN6021020023, 2014, pages 115016, ISSN: 0004735614 *
SCIENCE, vol. 342, JPN6021020024, 2013, pages 357 - 360, ISSN: 0004735615 *

Also Published As

Publication number Publication date
WO2017113786A1 (zh) 2017-07-06
CN109563492A (zh) 2019-04-02
BR112018013168A2 (pt) 2018-12-11
EP3399029A4 (en) 2019-07-17
US11510974B2 (en) 2022-11-29
CA3010015A1 (en) 2017-07-06
EP3399029A1 (en) 2018-11-07
AU2016383201A1 (en) 2018-07-05
CN109563492B (zh) 2023-05-12
CN106929482A (zh) 2017-07-07
US20200268870A1 (en) 2020-08-27
CO2018006706A2 (es) 2018-07-10
IL260258A (en) 2018-07-31
ZA201804362B (en) 2019-04-24

Similar Documents

Publication Publication Date Title
JP2019500051A (ja) 変異ウイルス、その調製方法およびその用途
JP4771959B2 (ja) インフルエンザウイルス作製のための多重プラスミド系
JP2023088962A (ja) インフルエンザウイルスワクチン及びその使用
ES2523587T3 (es) Virus influenza B que tienen alteraciones en el polipéptido hemaglutinina
JP5016731B2 (ja) 生弱毒化呼吸器合胞体ウイルス
CN105518129B (zh) 减毒流感疫苗和其用途
JP2015501141A (ja) インフルエンザヘマグルチニン変異体
CN103451158B (zh) 用于犬科动物中呼吸系统疾病控制的物质和方法
JP2011250798A5 (https=)
JP2012507302A5 (https=)
CN110305898A (zh) 哺乳动物细胞非易感h9n2亚型冷适应禽流感病毒的拯救
US20090162321A1 (en) Methods for packaging propagation-defective vesicular stomatitis virus vectors using a stable cell line that expresses g protein
CA2826234A1 (en) Novel vaccines against the a/h1n1 pandemic flu virus
WO2016134678A1 (zh) 新的甲型流感病毒哺乳动物细胞适应株及其制备和应用
CN112111503B (zh) 同时预防禽流感h5和h9亚型的腺病毒载体二价苗及其制备方法
CN103118704B (zh) 经修饰的病毒株及用于改善流感病毒的疫苗种子的产生的方法
CN111363728A (zh) 携带乙型肝炎病毒基因的重组甲型流感病毒、宿主细胞及其制备方法与应用
CN120683135A (zh) 嵌合表达新冠病毒rbd蛋白的甲型流感病毒样颗粒及其制备方法和应用
CN103316357B (zh) 携带rsv基因的重组流感病毒嵌合疫苗及其制备方法
CN105671002A (zh) H9n2亚型禽流感病毒细胞高产疫苗株构建及应用
CN110106193B (zh) 一种具有低受体结合活性的高致病性h7n9禽流感病毒抗原及其制备方法
CN103865923B (zh) 流感病毒为载体的HAdV嵌合疫苗的制备及其应用
KR101908905B1 (ko) 인플루엔자 바이러스의 h9 및 h5의 다중 아형에 대한 교차 면역반응을 형성하는 신규한 재조합 인플루엔자 바이러스 및 이를 포함하는 백신
CN116144612A (zh) 重组乙型流感病毒及其制备方法与应用
CN115960847B (zh) 小分子依赖的内含肽自剪接系统在制备减毒活疫苗中的应用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190515

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190515

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200608

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200907

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20201109

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201208

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210531

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210831

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20211029

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211130

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220328